FUS and amyotrophic lateral sclerosis: In order to truly understand whether FUS-RNA binding is a significant contributor to ALS pathogenesis, it may be necessary to use in vivo knock-in studies to perform physiologically relevant experiments (Lopez-Erauskin et al., 2018; Reber et al., 2018).